InfectoPharm develops effective preparations for specific medical requirements.
Since 1988, we focus on innovative pharmaceuticals for children and difficult-to-treat infections.
Today, InfectoPharm runs a highly diverse portfolio with more than 100 products and engages in about 30 strategic partnerships globally.
All our quality products offer unique benefits for the patient.
In 2017, the London Stock Exchange Group (LSEG) identified InfectoPharm as one of 1000 Companies to Inspire Europe and included us in their annual report highlighting the fastest growing and outstanding European SMEs.